Deactivation of a mutated Huntington protein in brains of mice can prevent very early symptoms, such as depression and anxiety, of Huntington's disease, according to researchers at Lund University.
Asa Petersen, Associate Professor of Neuroscience at Lund University, asserted that they're the first to show that it is possible to prevent the depression symptoms of Huntington's disease by deactivating the diseased protein in nerve cell populations in the hypothalamus in the brain.
Huntington's is a debilitating disease for which there is still neither cure nor sufficient treatment. The dance-like movements that characterise the disease have long been the focus for researchers, but the emotional problems affect the patient earlier than the motor symptoms.
"Now that we have been able to show in animal experiments that depression and anxiety occur very early in Huntington's disease, we want to identify more specifically which nerve cells in the hypothalamus are critical in the development of these symptoms. In the long run, this gives us better opportunities to develop more accurate treatments that can attack the mutated huntingtin where it does the most damage", said Petersen.
As the role of the hypothalamus in Huntington's disease is gradually mapped, knowledge might be gained from drug research for other psychiatric diseases.
It is likely that similar mechanisms control different types of depression, according to Petersen.